Overview
- 176 inspections across 124 sites are on record.
- 309 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2018-04-24.
At a glance
Inspections
176
Sites
124
Observations
309
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| PPL Healthcare LLC | 24 Apr 2018 | Human Drugs | View 483 → |
| Janssen Biotech, Inc. | 5 Mar 2018 | Human Drugs | On file |
| GlaxoSmithKline LLC | 26 Jan 2018 | Human Drugs | On file |
| Quotient Sciences - Philadelphia, LLC | 6 Nov 2017 | Human Drugs | View 483 → |
| Marlex Pharmaceuticals, Inc. | 6 Sep 2017 | Human Drugs |
Sites inspected
PPL Healthcare LLCSellersville, United States1 insp.
Janssen Biotech, Inc.Malvern, United States1 insp.
GlaxoSmithKline LLCConshohocken, United States1 insp.
Quotient Sciences - Philadelphia, LLCBoothwyn, United States1 insp.
Marlex Pharmaceuticals, Inc.New Castle, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Michael A Taylor6 shared
Marianela Aponte Cruz5 shared
Concepcion Cruz4 shared
Susanna E Ford3 shared
Monica E Caphart3 shared
Lisa B Orr2 shared
Michael L Casner2 shared
James M Mason2 shared
Julianne C Mccullough2 shared
Sharon K Thoma2 shared
Full investigator report
Get the verbatim findings behind Anita R Michael's 309 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site